GlassScriptPhysician profile
Thomas Hunter Mcmullen
NPI 1053872580
$3,569.97
in general payments reported to CMS, 2019-2025
9 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $112 · 2024: $2,910 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,907 · Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,907.31 |
| Food and Beverage | $1,524.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,931.89 | 2022-2024 | Scopis Ent, Na, Vsp System, Vsp Cranial |
| Inspire Medical Systems, INC. | $1,261.91 | 2024-2025 | Inspire |
| Abiomed | $111.48 | 2024 | Impella |
| Aerin Medical INC. | $93.33 | 2024-2025 | |
| Pfizer INC. | $51.24 | 2022 | |
| Zimmer Biomet Holdings, INC. | $41.63 | 2023 | Traumaone |
| Medtronic, INC. | $37.88 | 2024 | Stealthstation S8 Platform |
| Philips North America LLC | $25.03 | 2022 | |
| United Therapeutics Corporation | $15.58 | 2024 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcmullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.